COMMUNIQUÉS West-GlobeNewswire

Health Catalyst Reports Second Quarter 2024 Results
07/08/2024
SALT LAKE CITY, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported [...]
Catalyst Pharmaceuticals Reports Strong Second Quarter 2024 Financial Results and Provides Corporate Update
07/08/2024
Delivered Robust Revenue Performance, Fueled by Exceptional Commercial Execution and Early Success of the U.S. AGAMREE ® Product Launch Reported Record Q2 2024 Total Revenues of $122.7 Million, Representing a 23.2% YoY [...]
RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2024 Financial Guidance Ranges
07/08/2024
Total Company Revenue increased 13.9% to $459.7 million in the second quarter of 2024 from $403.7 million in the second quarter of 2023; Revenue from the Digital Health reportable segment (inclusive of intersegment [...]
OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results
07/08/2024
Conference call begins at 4:30 p.m. Eastern time today MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June [...]
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2024
07/08/2024
Conference Call Scheduled for Wednesday, August 14, 2024 at 9:00 AM ET PORTLAND, Maine, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health [...]
Revolution Medicines Reports Second Quarter 2024 Financial Results and Update on Corporate Progress
07/08/2024
Revolution Medicines to hold webcast today at 4:30 p.m. Eastern Time REDWOOD CITY, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company developing [...]
Jushi Holdings Inc. Reports Second Quarter 2024 Financial Results
07/08/2024
Margin Growth with Gross Profit and Gross Margin Reaching $32.6 Million and 50.4% , Respectively Net Loss of $1.9 Million , Compared to $14.0 Million in Q2 2023 Grew Adjusted EBITDA and Adjusted EBITDA Margin to $14.5 [...]
Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024
07/08/2024
Reported dose-dependent antitumor clinical activity in patients with relapsed/refractory triple-negative breast cancer from the Phase 1 trial of LYL797, a ROR1-targeted Chimeric Antigen Receptor (CAR) T‑cell product [...]
Telesis Bio Reports Second Quarter and First Half 2024 Financial Results
07/08/2024
SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leading provider of RNA and DNA solutions enabling researchers to accelerate therapeutic discovery through advanced, flexible, and rapid [...]
LifeMD Reports Second Quarter 2024 Results
07/08/2024
Revenue increased 41% year-over-year to $50.7 million with telehealth revenue up 67% Telehealth achieved standalone profitability one quarter ahead of guidance, with adjusted EBITDA of $820,000 Weight management [...]
Cartesian Therapeutics Announces New Employment Inducement Grants
07/08/2024
GAITHERSBURG, Md., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the “Company”), a clinical-stage biotechnology company developing mRNA cell therapies for the treatment of autoimmune [...]
ICU Medical Announces Second Quarter 2024 Results and Updates Its Fiscal Year 2024 Guidance
07/08/2024
SAN CLEMENTE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the [...]
Silk Road Medical Reports Second Quarter 2024 Financial Results
07/08/2024
SUNNYVALE, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today reported financial results for the three [...]
ClearPoint Neuro Reports Second Quarter 2024 Results
07/08/2024
Second Quarter Revenue Growth +32%; Record Revenue Achieved SOLANA BEACH, Aug. 07, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global device, cell, and gene therapy-enabling company [...]
Maravai LifeSciences Reports Second Quarter 2024 Financial Results
07/08/2024
Continued Focus on Product Portfolio Expansion, Market Leadership and Scientific Innovation SAN DIEGO, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of [...]
Atea Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
07/08/2024
Full Enrollment Achieved in Global Phase 2 Hepatitis C Virus (HCV) Study; Complete SVR12 Results Expected 4Q’24 Bemnifosbuvir and Ruzasvir HCV Data Presented at EASL: Support Best-in-Class Potential with High Antiviral [...]
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
07/08/2024
Positive data from a 12-week Phase 2a PET imaging trial demonstrated reduced total lung collagen, improved FVC and reduced cough severity in IPF patients treated with bexotegrast Positive long-term data from INTEGRIS- [...]
PacBio Announces Second Quarter 2024 Financial Results
07/08/2024
MENLO PARK, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB) today announced financial results for the quarter ended June 30, 2024. Second quarter results: Revenue of $36.0 million compared with $47.6 [...]
Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast
07/08/2024
TARRYTOWN, N.Y., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) announces the following September 2024 investor events: Investor Conference Presentations • Morgan Stanley 22 nd Annual [...]

Pages